June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Deciphera Pharmaceuticals (DCPH) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 22, 2025 (04:53)
Sector: HealthcareThe share price of Deciphera Pharmaceuticals, Inc. (DCPH) now
Are you interested in Deciphera Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Deciphera Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Deciphera Pharmaceuticals share be worth in 2025 - 2027?
When should I take profit in Deciphera Pharmaceuticals stock? When should I record a loss on Deciphera Pharmaceuticals stock? What are analysts' forecasts for Deciphera Pharmaceuticals stock? What is the future of Deciphera Pharmaceuticals stock? We forecast Deciphera Pharmaceuticals stock performance using neural networks based on historical data on Deciphera Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Deciphera Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Deciphera Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Deciphera Pharmaceuticals stock
The chart below shows the historical price of Deciphera Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Deciphera Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Deciphera Pharmaceuticals, Inc. is a clinical research biopharmaceutical company.
The company develops drugs designed to improve the lives of cancer patients. Her drug candidates include DCC-2618, DCC-3014 and (Rebastinib) Rebastinib. The platform of kinase switching inhibitors developed by the Company suppresses the process of kinase activation. DCC-2618 is an orally administered inhibitor of kinase switching control for the treatment of gastrointestinal stromal tumors (GIST), advanced systemic mastocytosis (ASM), gliomas including glioblastoma multiforme (GBM), and other solid tumors caused by the pan-KIT or PDGFR gene alpha. DCC-3014 is an orally administered potent and highly selective colony stimulating factor receptor 1 (CSF1R) inhibitor. Rebastinib is a potent and selective oral immunokinase inhibitor of TIE2. Rebastinib binds tightly to the binding region (pocket) of the TIE2 switch, stabilizing the inhibitory switch and displacing the activation switch to block TIE2 signaling.
Deciphera Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun 24 | 28.07 | 26.97 | 28.61 | 6.09 |
| Jun 25 | 28.50 | 27.75 | 29.20 | 5.24 |
| Jun 26 | 27.67 | 26.66 | 28.17 | 5.66 |
| Jun 27 | 27.99 | 27.10 | 28.79 | 6.25 |
| Jun 28 | 28.65 | 28.19 | 29.11 | 3.25 |
| Jun 29 | 28.42 | 28.05 | 28.73 | 2.43 |
| Jun 30 | 28.32 | 27.33 | 28.83 | 5.49 |
| Jul 01 | 28.08 | 26.99 | 28.92 | 7.18 |
| Jul 02 | 28.71 | 28.10 | 29.83 | 6.18 |
| Jul 03 | 29.17 | 28.21 | 29.65 | 5.12 |
| Jul 04 | 28.95 | 28.61 | 29.89 | 4.50 |
| Jul 05 | 28.87 | 28.52 | 29.46 | 3.29 |
| Jul 06 | 30.29 | 29.64 | 30.95 | 4.39 |
| Jul 07 | 30.28 | 29.46 | 30.66 | 4.06 |
| Jul 08 | 30.92 | 30.10 | 31.92 | 6.06 |
| Jul 09 | 31.05 | 30.60 | 32.06 | 4.77 |
| Jul 10 | 30.62 | 29.96 | 31.71 | 5.83 |
| Jul 11 | 31.54 | 30.88 | 32.48 | 5.21 |
| Jul 12 | 31.32 | 30.36 | 32.37 | 6.60 |
| Jul 13 | 31.83 | 30.61 | 32.18 | 5.15 |
| Jul 14 | 32.31 | 31.21 | 32.89 | 5.38 |
| Jul 15 | 32.18 | 31.44 | 33.47 | 6.45 |
| Jul 16 | 32.54 | 31.92 | 33.32 | 4.38 |
| Jul 17 | 32.67 | 31.95 | 33.60 | 5.16 |
| Jul 18 | 32.18 | 31.63 | 33.06 | 4.53 |
| Jul 19 | 31.79 | 30.76 | 32.59 | 5.94 |
| Jul 20 | 32.39 | 31.36 | 33.64 | 7.28 |
| Jul 21 | 31.99 | 30.95 | 33.24 | 7.39 |
| Jul 22 | 30.50 | 29.53 | 31.66 | 7.23 |
| Jul 23 | 29.28 | 28.29 | 29.85 | 5.54 |
Deciphera Pharmaceuticals Daily Price Targets
Deciphera Pharmaceuticals Stock Forecast 06-24-2025.
Forecast target price for 06-24-2025: $28.07.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.738%.
Pessimistic target level: 26.97
Optimistic target level: 28.61
Deciphera Pharmaceuticals Stock Forecast 06-25-2025.
Forecast target price for 06-25-2025: $28.50.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 4.978%.
Pessimistic target level: 27.75
Optimistic target level: 29.20
Deciphera Pharmaceuticals Stock Forecast 06-26-2025.
Forecast target price for 06-26-2025: $27.67.
Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.354%.
Pessimistic target level: 26.66
Optimistic target level: 28.17
Deciphera Pharmaceuticals Stock Forecast 06-27-2025.
Forecast target price for 06-27-2025: $27.99.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.882%.
Pessimistic target level: 27.10
Optimistic target level: 28.79
Deciphera Pharmaceuticals Stock Forecast 06-28-2025.
Forecast target price for 06-28-2025: $28.65.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 3.150%.
Pessimistic target level: 28.19
Optimistic target level: 29.11
Deciphera Pharmaceuticals Stock Forecast 06-29-2025.
Forecast target price for 06-29-2025: $28.42.
Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 2.374%.
Pessimistic target level: 28.05
Optimistic target level: 28.73
DCPH (DCPH) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 28.97 | 25.72 | 33.54 | 23.32 |
| Jul. | 30.71 | 29.48 | 34.76 | 15.19 |
| Aug. | 29.85 | 26.98 | 34.08 | 20.84 |
| Oct. | 25.31 | 22.58 | 27.64 | 18.32 |
| Oct. | 25.46 | 23.42 | 29.54 | 20.69 |
| Dec. | 28.01 | 25.09 | 32.15 | 21.95 |
| Dec. | 25.43 | 21.46 | 27.11 | 20.83 |
Deciphera Pharmaceuticals forecast for this year
Deciphera Pharmaceuticals Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $28.9679. Pessimistic: $25.72. Optimistic: $33.54
Deciphera Pharmaceuticals Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $30.706. Pessimistic: $29.48. Optimistic: $34.76
Deciphera Pharmaceuticals Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $29.8462. Pessimistic: $26.98. Optimistic: $34.08
Deciphera Pharmaceuticals Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $25.3096. Pessimistic: $22.58. Optimistic: $27.64
Deciphera Pharmaceuticals Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $25.4614. Pessimistic: $23.42. Optimistic: $29.54
Deciphera Pharmaceuticals Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $28.0076. Pessimistic: $25.09. Optimistic: $32.15
Deciphera Pharmaceuticals Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $25.4309. Pessimistic: $21.46. Optimistic: $27.11
Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 24.46 | 21.43 | 27.25 | 21.36 |
| Mar | 22.31 | 20.39 | 25.21 | 19.12 |
| Mar | 23.96 | 21.95 | 26.98 | 18.65 |
| May | 26.17 | 23.08 | 29.10 | 20.68 |
| May | 23.34 | 21.38 | 26.28 | 18.65 |
| Jul | 24.70 | 21.24 | 26.87 | 20.96 |
| Jul | 25.93 | 22.51 | 27.64 | 18.57 |
| Aug | 31.12 | 28.32 | 32.48 | 12.84 |
| Oct | 35.53 | 29.92 | 37.31 | 19.81 |
| Oct | 34.11 | 32.27 | 39.23 | 17.74 |
| Dec | 38.41 | 33.11 | 43.17 | 23.31 |
| Dec | 38.33 | 34.58 | 42.86 | 19.32 |
Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 35.88 | 33.44 | 39.25 | 14.81 |
| Mar | 37.96 | 34.85 | 43.50 | 19.90 |
| Mar | 39.86 | 33.96 | 45.68 | 25.65 |
| May | 33.32 | 30.79 | 35.99 | 14.44 |
| May | 37.99 | 35.78 | 40.57 | 11.80 |
| Jul | 37.68 | 34.52 | 41.90 | 17.63 |
| Jul | 40.02 | 34.02 | 43.70 | 22.16 |
| Aug | 41.14 | 37.77 | 46.49 | 18.76 |
| Oct | 42.87 | 40.90 | 45.44 | 10.00 |
| Oct | 34.72 | 32.71 | 40.14 | 18.51 |
| Dec | 34.10 | 30.42 | 36.35 | 16.32 |
| Dec | 34.78 | 32.07 | 38.75 | 17.24 |
Deciphera Pharmaceuticals information and performance
N/A
Market capitalization of the Deciphera Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DCPH shares in the company outstanding by the market price of one share.
EBITDA of Deciphera Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Deciphera Pharmaceuticals Stock)
Should I Buy Deciphera Pharmaceuticals Shares in 2025 year?
Does Deciphera Pharmaceuticals pay dividends?
Which economic sector do Deciphera Pharmaceuticals's shares belong to?
Which other securities belong to the same sector as Deciphera Pharmaceuticals's shares?
Related stocks from Healthcare sector
